Table 1 |
||
|
Characteristics of subjects evaluated for autoantibodies. |
||
| CFS |
Non-Fatigued |
|
|
|
||
| Atlanta Case Control |
||
| Subjects (n = 56) |
22 |
34 |
| Female (n = 52) |
19 |
33 |
| Male (n = 4) |
3 |
1 |
| Age Group (yrs) |
||
| 18–29 (n = 9) |
3 |
6 |
| 30–39 (n = 18) |
7 |
11 |
| 40–49 (n = 23) |
12 |
11 |
| 50–59 (n = 6) |
0 |
6 |
| Mean Age |
39 years |
38 years |
| Mean Age Onset |
35 years |
|
| Onset type |
||
| Sudden |
8 |
|
| Gradual |
14 |
|
| Mean Illness Duration |
69 months |
|
| Number of Subjects Ill |
||
| < 5 years |
10 |
|
| >5 years |
12 |
|
| Wichita Population |
||
| Subjects (n = 94) |
37 |
57 |
| Female (n = 64) |
31 |
33 |
| Male (n = 30) |
6 |
24 |
| Age Group (yrs) |
||
| 18–29 (n = 14) |
1 |
13 |
| 30–39 (n = 18) |
8 |
10 |
| 40–49 (n = 26) |
13 |
13 |
| 50–69 (n = 36) |
15 |
21 |
| Mean Age |
46 years |
42 years |
| Mean Age Onset |
36 years |
|
| Onset type |
||
| Sudden |
5 |
|
| Gradual |
32 |
|
| Mean Illness Duration |
128 months |
|
| Number of Subjects Ill |
||
| < 5 years |
14 |
|
| >5 years |
23 |
|
Vernon and Reeves Journal of Autoimmune Diseases 2005 2:5 doi:10.1186/1740-2557-2-5 |
||
